Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic S7

This article was originally published in The Gray Sheet

Executive Summary

Seventh-generation AVE coronary stent system receives FDA approval, firm announces April 5. The S7 boasts shorter element lengths (1 mm) and a smaller cross-sectional area, providing additional flexibility to track through complex anatomy and reach difficult lesions that its S670 predecessor cannot. Device incorporates patented Discrete technology and offers perfusion capabilities at an average rate of 2 cc/minute at nominal pressure. Shipments began immediately to interventional cardiologists in the U.S. and abroad
UsernamePublicRestriction

Register

MT014724

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel